Ziad Gellad MD, MPH, AGAF

Ziad Gellad

Core Faculty

Ziad Gellad, MD, MPH, AGAF

Degrees

MD, Johns Hopkins University

MPH, Johns Hopkins University

Dr. Gellad is an associate professor of medicine in the Division of Gastroenterology at Duke University Medical Center and a faculty member of the Duke Clinical Research Institute.  He is also a VA Career Development Awardee and holds an appointment in the Health Services Research and Development Center of Innovation at the Durham VA Medical Center.  His research focuses on the implementation of systems engineering methods to improve the quality and value of health care delivery with a specific emphasis in colorectal cancer screening.

Dr. Gellad has also received several innovation grants to develop and implement novel information technology platforms to improve the patient and clinician experience.  He is also an active contributor to the innovation and entrepreneurship activities within Duke University and co-founder of a health technology startup in Durham.

He is the Director of Quality for the Division of Gastroenterology and Associate vice Chair for Clinical Innovation in the Department of Medicine at Duke University Medical Center.   Dr. Gellad is past-chair of the Quality Measures Committee of the American Gastroenterological Association, associate editor for GI & Hepatology News and is on the Board of Editors for Clinical Gastroenterology and Hepatology

Dr. Gellad received his MD and MPH degrees from Johns Hopkins University.  He completed a residency in internal medicine and a fellowship in gastroenterology at Duke University Medical Center. 

Kobe EA, Sullivan BA, Qin X, Redding TS, Hauser ER, Madison AN, et al. Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort. Gastrointest Endosc. 2022 Sep;96(3):553-562.e3.

Venkatraman V, Ponder M, Gellad ZF, Lad SP, Christy E, Plichta R, et al. Feasibility study of a novel digital health platform for patients undergoing transcatheter aortic valve replacement. J Card Surg. 2022 Jul;37(7):2017–22.

Sullivan BA, Redding TS, Qin X, Gellad ZF, Hauser ER, O’Leary MC, et al. Ten or More Cumulative Lifetime Adenomas Are Associated with Increased Risk for Advanced Neoplasia and Colorectal Cancer. Dig Dis Sci. 2022 Jun;67(6):2526–34.